Valuation: Cochlear Limited

Market Cap 10.17B 6.98B 6.26B 5.72B 5.22B 9.85B 655B 69.02B 27.65B 350B 26.19B 25.63B 1,106B P/E 2027 *
34.6x
P/E 2028 * 27.5x
Enterprise Value 9.94B 6.82B 6.12B 5.59B 5.11B 9.63B 640B 67.45B 27.03B 342B 25.6B 25.05B 1,081B EV / Sales 2027 *
4.2x
EV / Sales 2028 * 3.94x
Free-Float
99.42%
Yield 2027 *
2.31%
Yield 2028 * 2.56%
1 day+0.67%
1 week+9.33%
Current month+8.24%
1 month+18.99%
3 months+27.43%
6 months+56.30%
Current year-40.36%
1 week 139.08
Extreme 139.08
155.47
1 month 125.61
Extreme 125.61
155.47
Current year 88.74
Extreme 88.74
278.35
1 year 88.74
Extreme 88.74
291.2
3 years 88.74
Extreme 88.74
350.31
5 years 88.74
Extreme 88.74
350.31
10 years 88.74
Extreme 88.74
350.31
Manager TitleAgeSince
Chief Executive Officer - 03/01/2018
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - 01/07/2019
Director TitleAgeSince
Chairman 58 21/08/2021
Director/Board Member - 14/11/2017
Director/Board Member 69 13/12/2016
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Buy

Director

1,100 0.0017%
24/08/26 Buy

Director

444 0.0007%
24/08/26 Buy

Director

257 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.67%+9.33%-45.41%-37.20% 7.03B
-3.23%+5.13%-11.73%+14.70% 197B
-2.75%+4.53%-8.89%+17.97% 128B
-2.90%+4.83%+12.61%+40.30% 128B
+0.96%+8.75%-38.73%+11.23% 99B
-1.80%+0.92%-5.77%+70.91% 64.82B
-0.78%+6.83%+20.12%-18.16% 58.17B
+0.79%+17.37%-6.13%+57.47% 52.84B
-6.98%-14.94%-9.70%+46.32% 50.69B
-2.36%+4.32%+2.44%-8.53% 37.23B
Average -1.84%+7.20%-9.12%+19.50% 82.24B
Weighted average by Cap. -2.21%+7.57%-7.18%+24.09%

Financials

2027 *2028 *
Net sales 2.37B 1.63B 1.46B 1.33B 1.22B 2.3B 153B 16.08B 6.44B 81.55B 6.1B 5.97B 258B 2.5B 1.72B 1.54B 1.41B 1.28B 2.42B 161B 16.97B 6.8B 86.08B 6.44B 6.3B 272B
Net income 292M 200M 180M 164M 150M 283M 18.82B 1.98B 794M 10.06B 752M 736M 31.78B 369M 254M 228M 208M 190M 358M 23.81B 2.51B 1B 12.72B 952M 931M 40.2B
Net Debt -231M -158M -142M -130M -119M -224M -14.88B -1.57B -628M -7.95B -595M -582M -25.12B -313M -215M -193M -176M -161M -303M -20.15B -2.12B -851M -10.77B -806M -788M -34.02B
Projected Income Statement - Annual - Cochlear Limited
Logo Cochlear Limited
Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services and Acoustics. The Cochlear Implants segment offers Cochlear implant systems. The Services segment offers sound processor upgrades, accessories and other. The Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Employees
5,400
Date Price Change Volume
06/11/26 A$155.47 +0.67% 443,692
05/11/26 A$154.44 +8.65% 453,231
04/11/26 A$142.15 +0.26% 295,353
03/11/26 A$141.78 +0.44% 271,795
02/11/26 A$141.16 -1.73% 443,197
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Cochlear Limited
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
155.47AUD
Average target price
136.34AUD
Spread / Average Target
-12.30%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cochlear Limited